Skip to content

Dr. PELCKMANS M.C.: what changed

You see two financial years side by side: what moved most in the balance sheet and the result, why the result rose or fell and where the money went.

What changed

Dr. PELCKMANS M.C.

BE 0451.654.863
NACE 86.220, Specialist medical practice
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€11,223
2024 · -€93,843+€82,619
Equity
€173,596
2024 · €284,819-€111,223
Cash
€6,280
2024 · €165,895-€159,615
Balance sheet total
€187,187
2024 · €314,244-€127,057

Largest movements

2024 to 2025
Assets
  • Cash -€159,615

    down €159,615 (-96.2%), from €165,895 to €6,280

    mainly Receivables after one year (-€150,000) and Contributions, distributions and other (-€100,000)

  • Receivables after one year +€150,000

    new in 2025: €150,000

  • Current investments -€103,789

    no longer reported in 2025 (was €103,789)

  • Receivables within one year -€11,368

    down €11,368 (-39.0%), from €29,158 to €17,790

    of which Other amounts receivable: -€11,673

Equity and liabilities
  • Reserves -€100,000

    down €100,000 (-19.5%), from €511,720 to €411,720

    of which Distributable reserves: -€100,000

  • Other debts -€12,520

    down €12,520 (-56.9%), from €22,000 to €9,480

  • Profit (loss) carried forward -€11,223

    down €11,223 (-4.1%), from -€272,298 to -€283,522

Income statement
  • Gross operating margin +€7,249

    up €7,249 (+56.9%), from -€12,734 to -€5,484

  • Other operating charges +€3,813

    up €3,813 (+713%), from €535 to €4,347

  • Depreciation -€1,275

    down €1,275 (-46.0%), from €2,773 to €1,498

  • Financial charges -€240

    down €240 (-80.1%), from €300 to €60

  • Financial income +€165

    up €165 (+826,200%), from €0 to €165

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€93,843
Gross operating margin +€7,249
Depreciation +€1,275
Other operating charges -€3,813
Other operating items +€77,502
Financial income +€165
Financial charges +€240
Result 2025 -€11,223
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€163,404
Investment +€103,789
Financing -€100,000
Cash 2024 €165,895
Net result for the year -€11,223
Depreciation +€1,498
Receivables after one year -€150,000
Receivables within one year +€11,368
Deferred charges and accrued income +€788
Trade debts -€2,999
Tax, wage and social debts -€315
Other debts -€12,520
Current investments +€103,789
Contributions, distributions and other -€100,000
Cash 2025 €6,280
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €314,244 €187,187 -€127,057 -40.4%
Fixed assets 21/28 €6,824 €5,326 -€1,498 -22.0%
Tangible fixed assets 22/27 €6,824 €5,326 -€1,498 -22.0%
Land and buildings 22 €738 €461 -€277 -37.5%
Plant, machinery and equipment 23 €1,532 €416 -€1,116 -72.8%
Furniture and vehicles 24 €106 €0 -€106 -100%
Other tangible fixed assets 26 €4,449 €4,449 = 0.0%
Current assets 29/58 €307,420 €181,862 -€125,559 -40.8%
Amounts receivable after more than one year 29 - €150,000 +€150,000
Other amounts receivable 291 - €150,000 +€150,000
Stocks and contracts in progress 3 €7,792 €7,792 = 0.0%
Stocks 30/36 €7,792 €7,792 = 0.0%
Amounts receivable within one year 40/41 €29,158 €17,790 -€11,368 -39.0%
Trade receivables 40 €17,028 €17,333 +€305 +1.8%
Other amounts receivable 41 €12,130 €457 -€11,673 -96.2%
Current investments 50/53 €103,789 - -€103,789
Cash at bank and in hand 54/58 €165,895 €6,280 -€159,615 -96.2%
Deferred charges and accrued income 490/1 €788 - -€788
Total equity and liabilities 10/49 €314,244 €187,187 -€127,057 -40.4%
Equity 10/15 €284,819 €173,596 -€111,223 -39.1%
Contributions 10/11 €45,397 €45,397 = 0.0%
Reserves 13 €511,720 €411,720 -€100,000 -19.5%
Tax-exempt reserves 132 €28,306 €28,306 = 0.0%
Distributable reserves 133 €483,414 €383,414 -€100,000 -20.7%
Profit (loss) carried forward 14 -€272,298 -€283,522 -€11,223 -4.1%
Amounts payable 17/49 €29,425 €13,591 -€15,834 -53.8%
Amounts payable within one year 42/48 €29,425 €13,591 -€15,834 -53.8%
Trade debts 44 €5,110 €2,111 -€2,999 -58.7%
Suppliers 440/4 €5,110 €2,111 -€2,999 -58.7%
Taxes, remuneration and social security 45 €2,315 €2,000 -€315 -13.6%
Taxes 450/3 €2,315 €2,000 -€315 -13.6%
Other amounts payable 47/48 €22,000 €9,480 -€12,520 -56.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,773 €1,498 -€1,275 -46.0%
Other operating charges 640/8 €535 €4,347 +€3,813 +713%
Non-recurring operating charges 66A €77,502 - -€77,502
Gross operating margin 9900 -€12,734 -€5,484 +€7,249 +56.9%
Operating profit (loss) 9901 -€93,543 -€11,329 +€82,214 +87.9%
Financial income 75/76B €0 €165 +€165 +826,200%
Recurring financial income 75 €0 €165 +€165 +826,200%
Financial charges 65/66B €300 €60 -€240 -80.1%
Recurring financial charges 65 €300 €60 -€240 -80.1%
Profit (loss) for the period before taxes 9903 -€93,843 -€11,223 +€82,619 +88.0%
Profit (loss) for the period 9904 -€93,843 -€11,223 +€82,619 +88.0%
Profit (loss) for the period to be appropriated 9905 -€93,843 -€11,223 +€82,619 +88.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.